Pyrimidine pyrazolyl derivatives
US9216991B2 · kind B2 · utility
5Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2013 |
| Grant date | Dec 22, 2015 |
| Priority date | — |
| Expiry date | Jul 3, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds of Formula (I) for the treatment of cancer, rheumatoid arthritis and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.